ATE505535T1 - Verfahren zur herstellung stabiler b-lymphozyten - Google Patents

Verfahren zur herstellung stabiler b-lymphozyten

Info

Publication number
ATE505535T1
ATE505535T1 AT06842246T AT06842246T ATE505535T1 AT E505535 T1 ATE505535 T1 AT E505535T1 AT 06842246 T AT06842246 T AT 06842246T AT 06842246 T AT06842246 T AT 06842246T AT E505535 T1 ATE505535 T1 AT E505535T1
Authority
AT
Austria
Prior art keywords
lymphocytes
producing stable
producing
stable
methods
Prior art date
Application number
AT06842246T
Other languages
English (en)
Inventor
Herman Groen
Hans Westra
Original Assignee
Iq Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iq Corp filed Critical Iq Corp
Application granted granted Critical
Publication of ATE505535T1 publication Critical patent/ATE505535T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT06842246T 2005-08-23 2006-08-23 Verfahren zur herstellung stabiler b-lymphozyten ATE505535T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71062605P 2005-08-23 2005-08-23
PCT/IB2006/003670 WO2007063415A2 (en) 2005-08-23 2006-08-23 Methods of producing stable b-lymphocytes

Publications (1)

Publication Number Publication Date
ATE505535T1 true ATE505535T1 (de) 2011-04-15

Family

ID=37968195

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06842246T ATE505535T1 (de) 2005-08-23 2006-08-23 Verfahren zur herstellung stabiler b-lymphozyten

Country Status (6)

Country Link
US (2) US20070065919A1 (de)
EP (1) EP1928999B1 (de)
AT (1) ATE505535T1 (de)
CA (1) CA2619784A1 (de)
DE (1) DE602006021324D1 (de)
WO (2) WO2007063415A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1974020T3 (pl) * 2005-12-16 2011-11-30 Ribovax Biotechnologies Sa Sposoby uzyskiwania unieśmiertelnionych komórek wydzielających przeciwciała
JP5797403B2 (ja) 2007-08-03 2015-10-21 エムユーエスシー ファウンデーション フォー リサーチ ディベロップメント ヒトモノクローナル抗体およびそれを産生する方法
EP2242836B1 (de) * 2008-01-28 2015-05-20 Thomas Jefferson University Verfahren zur herstellung von hybridzellen zur expression nützlicher antikörper
CA2738176C (en) 2008-09-23 2012-01-10 Hema-Quebec Method for polyclonal immunoglobulin g production by human b cells
US20110129460A1 (en) * 2009-01-14 2011-06-02 IQ Therapeutics B.V. Combination Antibodies For The Treatment And Prevention Of Disease Caused By Bacillus Anthracis And Related Bacteria And Their Toxins
US9260517B2 (en) 2009-11-17 2016-02-16 Musc Foundation For Research Development Human monoclonal antibodies to human nucleolin
EP3436571B1 (de) 2016-03-30 2023-06-14 F. Hoffmann-La Roche AG Verfahren zur kultivierung von b-zellen
US11406975B2 (en) 2016-07-18 2022-08-09 President And Fellows Of Harvard College Human lymphoid tissue-on-chip
JP6916884B2 (ja) 2017-01-02 2021-08-11 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ Ｂ細胞培養法
WO2018210896A1 (en) 2017-05-19 2018-11-22 F. Hoffmann-La Roche Ag Method for the production of thymocyte supernatant
WO2019105864A1 (en) 2017-11-30 2019-06-06 F. Hoffmann-La Roche Ag B-cell cultivation method
WO2021027057A1 (zh) * 2019-08-15 2021-02-18 成都冕康生物科技有限公司 一种针对ebv病毒抗原的b细胞疫苗及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5126259A (en) * 1987-12-24 1992-06-30 Takeda Chemical Industries, Ltd. Human b. lymphoblastoid cell, hybridoma, antibody and production of antibody
JPH02131574A (ja) * 1988-06-17 1990-05-21 Biogenex Lab ミニクローン
WO1990000404A1 (en) * 1988-07-15 1990-01-25 United Biotech, Inc. Enrichment of antigen-specific polyclonal antibodies through selection of immortal hybrid cells
DE69126281T2 (de) 1990-11-26 1997-10-16 Akzo Nobel Nv Verfahren zur Herstellung von Antikörpern
DE4134297A1 (de) * 1991-10-17 1993-04-22 Behringwerke Ag Monoclonale antikoerper gegen mycoplasma pneumoniae, diese produzierende hybridome, verfahren zu deren herstellung sowie deren verwendung
AU3805893A (en) * 1992-03-19 1993-10-21 U.S. Government, As Represented By The Secretary Of The Army Broadly reactive opsonic antibodies that react with common staphylococcal antigens
ES2251719T3 (es) 1994-04-28 2006-05-01 Boehringer Ingelheim Pharmaceuticals Inc. Metodos para la proliferacion y diferenciacion de celulas b y su empleo.
FI98493C (fi) * 1994-06-10 1997-07-10 Olavi Kajander Kasvutekijävalmiste, menetelmä sen valmistamiseksi ja käyttämiseksi ja sitä sisältävä elatusaine
US7115264B2 (en) 2001-11-05 2006-10-03 Inhibitex Monoclonal antibodies to the fibronectin binding protein and method of use in treating or preventing infections
US7169903B2 (en) * 2001-12-21 2007-01-30 Biosynexus Incorporated Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria
US20110129412A1 (en) * 2005-06-02 2011-06-02 Astrazeneca Ab Antibodies Directed to CD20 and Uses Thereof

Also Published As

Publication number Publication date
CA2619784A1 (en) 2007-06-07
WO2007049152A3 (en) 2007-10-04
US20070098711A1 (en) 2007-05-03
US7807415B2 (en) 2010-10-05
EP1928999A2 (de) 2008-06-11
WO2007049152A2 (en) 2007-05-03
WO2007063415A2 (en) 2007-06-07
EP1928999B1 (de) 2011-04-13
DE602006021324D1 (de) 2011-05-26
US20070065919A1 (en) 2007-03-22
WO2007063415A3 (en) 2007-11-01

Similar Documents

Publication Publication Date Title
ATE505535T1 (de) Verfahren zur herstellung stabiler b-lymphozyten
ATE425136T1 (de) Verfahren zur herstellung substituierter 3-aryl- butyl-aminverbindungen
ATE464908T1 (de) Verfahren zur behandlung von osteoarthritis mit anti-il-6 antikörpern
ATE435209T1 (de) Verfahren zur herstellung von montelukast-natrium
ATE408609T1 (de) Verfahren zur herstellung von n-phenylpyrazol-1- carboxamiden
DE602006012274D1 (de) Verfahren und Vorrichtung zur Herstellung von Gruppe III Nitridkristall.
ATE430480T1 (de) Verfahren zur herstellung von nährmittelzusammensetzungen
ATE408604T1 (de) Verfahren zur herstellung von 1-alkyl-3- phenyluracilen
ATE440888T1 (de) Verfahren zur herstellung von glatiramer
DE602005007219D1 (de) Verfahren und Vorrichtung zur Trennung von Schallquellensignalen
ATE482966T1 (de) Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
ATE349408T1 (de) Verfahren zur herstellung verzweigter kohlenwasserstoffe
ATE554390T1 (de) Verfahren zur gewinnung von antikörpern
ATE456666T1 (de) Verfahren zur auswertung von ribonukleotidsequenzen
DE602006013151D1 (de) Verfahren zur herstellung von polymermaleimiden
ATE437906T1 (de) Verfahren zur herstellung von pfropfpolymerisaten
ATE465277T1 (de) Verfahren zur herstellung von leder
ATE444303T1 (de) Verfahren zur herstellung von ferrisuccinylcasein
ATE549314T1 (de) Verfahren zur herstellung von 4-aminochinazolinen
DE602005012211D1 (de) Verfahren zur Herstellung von Flugtriebwerksgehäusen mit Flanschen
ATE546524T1 (de) Verfahren zur herstellung aktiver scfv-antikörper und bibliotheken dafür
ATE405374T1 (de) Verfahren zur herstellung von brillengläsern
WO2008052108A3 (en) Methods for use in human-adapting monoclonal antibodies
ATE544783T1 (de) Neutralisierende anti tlr4/md-2 antikörper und verfahren zu deren verwendung
DE102005025040B4 (de) Verfahren und Vorrichtung zur Erzeugung von methanreichem Biogas

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties